Danielle Novascone was hooked on OxyContin for about a year when it suddenly got a lot harder to get high.
For years, people like Novascone crushed the pills and snorted the powder for an instant fix. In 2010, OxyContin’s manufacturer, Purdue Pharma, changed the opioid painkiller to supposedly stem the abuse epidemic it ignited. When new “abuse-deterrent” OxyContin was crushed, it would turn to jelly, Novascone said.
“It didn’t stop a damn thing,” she added.
Like a burglar confronted with a new safe, Novascone came up with novel methods to break in.
Novascone would shave the pills down with a metal file or chisel, then microwave or bake the jelly until it hardened, crush it and snort or inject it just like the old Oxy.
“It would take 45 minutes to set up one pill,” she said. “It became a pain in the ass.”
When Novascone realized she could buy heroin already in powder form at a fraction of the cost of OxyContin, she switched without hesitation.
New research by the University of Pennsylvania’s Wharton School and the RAND Corporation has found OxyContin users like Novascone made the jump to heroin and thousands didn’t survive.
“Our results, imply that a substantial share of the dramatic increase in heroin deaths since 2010 can be attributed to the reformulation of OxyContin,” the study’s authors wrote.
As much as 80 percent of the three-fold increase in heroin mortality since 2010 can be attributed to OxyContin’s reformulation, the study concluded.
As dangerous as Oxy can be, it is at least regulated by federal government and produced uniformly by a pharmaceutical company. Heroin, on the other hand, is is increasingly cut with fentanyl, an opioid as much as 80 times stronger than morphine.
Using the study’s estimate, that means the reformulation likely caused more than 7,500 additional heroin deaths.
In 2010, the year Purdue rolled out the new formula, there were 3,038 heroin deaths in the United States, according to the Centers for Disease Control and Prevention. By 2013, the death toll jumped to 8,260. Since then heroin deaths have continued to climb, hitting a record high of 12,989 in 2015, the latest year for which there is data.
“The reformulation totally screwed up our game,” said Kevin Joyce, 53, who started out using OxyContin before 2010. “We eventually moved to heroin and our addiction’s got worse.”
“In the past two years 7 of my friends have died,” Joyce said.
Purdue Pharma responded to the study in a statement to The Daily Beast.
“The White House, FDA, and DEA consider abuse-deterrent technology to be an important part of a comprehensive approach toward combating prescription drug abuse,” Purdue said, adding drug treatment and prevention should be part of that approach.
Despite previous studies that link OxyContin’s reformulation to increased heroin use, the CDC maintains that there is no causal link between supply reductions in prescription painkillers and the rise in heroin deaths.
It’s the second time in as many decades that Purdue Pharma tried to make its drug safer.
OxyContin was rolled out in 1996 and aggressively marketed by Purdue and pharmaceutical-giant Abbott Laboratories as a wonder drug for pain that only needed to be taken twice a day. Other painkillers like Vicodin would wear off after 4 to 6 hours, requiring several daily doses to relieve pain. Oxycontin, on the other hand, supposedly lasted 12 hours, requiring only two doses.
In advertisements for OxyContin, doctors paid by Purdue misrepresented the risk of the drug’s addiction potential.
“The rate of addiction amongst pain patients who are treated by doctors is much less than one percent,” a doctor said in this video advertisement made by Purdue. Though the risk of addiction in the chronic pain population is debatable, the problem is OxyContin was over prescribed and massively diverted from the medical system.
A Los Angeles Times investigation revealed that Purdue knew their blockbuster drug’s effects didn’t last that long. So they told doctors to prescribe stronger and stronger doses, increasing the risk of overdose for thousands of patients. The “extended-release formula” that supposedly made OxyContin safe was a total sham.
The marketing scheme was brought to light in 2007 when Purdue pleaded guilty to misleading doctors and regulators. The company paid out $600 million in fines and to this day is still fending off lawsuits by states that see the Purdue’s marketing campaign responsible for killing hundreds of its residents.